Endogenous and exogenous hormone exposure and risk of cognitive impairment in Swedish twins: A preliminary study

Psychoneuroendocrinology

Volumn 30, Issue 6, 2005, Pages 558-567

  Rasgon, Natalie L ^a   Magnusson, Cecilia ^b   Johansson, Anna L V ^b   Pedersen, Nancy L ^b,c   Elman, Shana ^d   Gatz, Margaret ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognitive impairment; Endogenous hormone exposure; Hormone replacement therapy; Swedish twins

Indexed keywords

ESTROGEN;

AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; PARITY; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; RISK ASSESSMENT; SWEDEN; TELEPHONE; TWINS;

EID: 16244395168     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2005.01.004     Document Type: Article

References (44)

1. L. Amaducci, L. Fratiglioni, W. Rocca, C. Fieschi, P. Livrea, D. Pedone, L. Bracco, A. Lippi, C. Gandolfo, and G. Bino Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population Neurology 36 1986 922 931
2. M. Baldereschi, A. Di Carlo, V. Lepore, L. Bracco, S. Maggi, F. Grigoletto, G. Scarlato, and L. Amaducci Estrogen-replacement therapy and Alzheimer's disease in the Italian longitudinal study on aging Neurology 50 1998 996 1002
3. E. Barrett-Connor, and D. Kritz-Silverstein Estrogen replacement therapy and cognitive function in older women JAMA 269 1993 2637 2641
4. R. Bartus, R. Dean, and B. Beer An evaluation of drugs for improving memory in aged monkeys: implications for clinical trials in humans Psychopharmacol. Bull. 10 1983 168 184
5. S. Birge The role of estrogen in the treatment and prevention of dementia: introduction Am. J. Med. 103 1997 1S 2S
6. D. Brenner, W. Kukull, A. Stergachis, G. van Belle, J. Bowen, W. McCormick, L. Teri, and E. Larson Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease Am. J. Epidemiol. 140 1994 262 267
7. S. Craft, S. Asthana, G. Schellenberg, M. Cherrier, L. Baker, J. Newcomer, S. Plymate, S. Latendresse, A. Petrova, M. Raskind, E. Peskind, and C. Lofgreen Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender Neuroendocrinology 70 1999 146 152
8. rR. Fuhre, C. Dufouil, and J. Dartigues Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study J. Am. Geriatr. Soc. 51 2003 1055 1063
9. J. Gallo, and J. Breitner Alzheimer's disease in the NAS-NRC Registry of aging twin veterans, IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia Psychol. Med. 25 1995 1211 1219
10. M. Gatz, C. Reynolds, J. Nikolic, B. Lowe, M. Karel, and N. Pedersen An empirical test of telephone screening to identify potential dementia cases Int. Psychogeriatr. 7 1995 429 438
11. M. Gatz, C. Reynolds, R. John, B. Johansson, J. Mortimer, and N. Pedersen Telephone screening to identify potential dementia cases in a population-based sample of older adults Int. Psychogeriatr. 14 2002 273 289
12. Gatz, M., Fratiglioni, L., Johansson, B., Berg, S., Mortimer, J., Reynolds, C., et al., in press. Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study. Neurobiol. Aging.
13. M. Geerlings, A. Ruitenberg, J. Witteman, J. van Sweiten, A. Hofman, C. van Duijn, M. Breteler, and L. Launer Reproductive period and risk of dementia in postmenopausal women JAMA 285 2001 1475 1481
14. R. Gibbs Estrogen and nerve growth factor-related systems in brain: effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging Ann. NY Acad. Sci. 743 1994 165 199
15. R. Gibbs, and P. Aggarwal Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline Horm. Behav. 34 1998 98 111
16. E. Gould, C. Woolley, M. Frankfurt, and B. McEwen Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood Neuroscience 10 1990 1286 1291
17. D. Grady, K. Yaffe, M. Kristof, F. Lin, C. Richards, and E. Barrett-Connor Effect of postmenopausal hormone therapy on cognitive function: the heart and estrogen/progesterin replacement study Am. J. Med. 113 2002 612 613
18. S. Helgason, M. Damber, B. von Schoultz, and T. Stigbrand Estrogenic potency of oral replacement therapy estimated by the induction of pregnancy zone protein Acta Obstet. Gynecol. Scand. 61 1982 75 79
19. A. Heyman, W. Wilkinson, J. Stafford, M. Helms, A. Sigmon, and T. Weinberg Alzheimer's disease: a study of epidemiological aspects Ann. Neurol. 15 1984 335 341
20. E. Hogervost, J. Williams, M. Budge, W. Riedel, and J. Jolles The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis Neuroscience 101 2000 485 512
21. K. Horsburgh, I. Macrae, and H. Carswell Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global aschemia J. Cereb. Blood Flow. Metab. 22 2002 1189 1195
22. D. Jacobs, M. Tang, Y. Stern, M. Sano, K. Marder, K. Bell, P. Schofield, G. Dooneief, B. Gurland, and R. Mayeux Cognitive function in nondemented older women who took estrogen after menopause Neurology 50 1998 368 373
23. A. Jaffe, D. Toran-Allerand, P. Greengard, and S. Gandy Estrogen regulates metabolism of Alzheimer amyloid-beta precursor protein J. Biol. Chem. 269 1994 13065 13068
24. T. Järvenpää, J. Rinne, I. Raiha, M. Koskenvuo, M. Lopponen, S. Hinkka, and J. Kaprio Characteristics of two telephone screens for cognitive impairment Dement. Geriatr. Cogn. Disord. 13 2002 149 155
25. R. Kahn, A. Goldfarb, M. Pollack, and A. Peck Brief objective measures for the determination of mental status in the aged Am. J. Psychiatr. 117 1960 326 328
26. C. Kawas, S. Resnick, A. Morrison, R. Brookmeyer, M. Corrada, A. Zonderman, C. Bacal, D. Lingle, and E. Metter A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the baltimore longitudinal study of aging Neurology 48 1997 1517 1521
27. K. Kendler, C. Prescott, J. Myers, and M. Neale The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women Arch. Gen. Psychiatry 60 2003 929 937
28. D. Kimura Estrogen replacement therapy may protect against decline in postmenopausal women Horm. Behav. 29 1995 312 321
29. P. Lichtenstein, U. De Faire, B. Floderus, M. Svartengren, P. Svedberg, and N. Pedersen The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies J. Intern. Med. 252 2002 184 205
30. K. Matthews, J. Cauley, K. Yaffe, and J. Zmuda Estrogen replacement therapy and cognitive decline in older community women J. Am. Geriatr. Soc. 47 1999 518 523
31. B. McEwen, and S. Alves Estrogen actions in the central nervous system Endocr. Rev. 20 1999 279 307
32. K. Miller, J. Conney, N. Rasgon, L. Fairbanks, and G. Small Estrogen, cognition, and mood functioning JAGS 50 2002 1826 1830
33. J. Nilsen, and R. Brinton Impact of progestins on estradiol potentiation of the glutamate calcium response Neuroreport 13 2002 825 830
34. A. Paganini-Hill, and V. Henderson Estrogen deficiency and risk of Alzheimer's disease in women Am. J. Epidemiol. 140 1994 256 261
35. S. Resnick, J. Metter, and A. Zonderman Estrogen replacement therapy and longitudinal decline in visual memory Neurology 49 1997 1491 1497
36. SAS Institute, 1996. SAS/STAT software: changes and enhancements through release 6.11.1104.
37. S. Shumaker, C. Legault, S. Rapp, L. Thal, R. Wallace, and J. Ockene Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the women's health initiaitve memory study: a randomized controlled trial JAMA 289 2003 2651 2662
38. S. Shumaker, C. Legault, L. Kuller, S. Rapp, L. Thal, and D. Lane Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: women's health initiative memory study JAMA 291 2004 2947 2958
39. M. Tang, D. Jacobs, Y. Stern, K. Marder, P. Schofield, B. Gurland, H. Andrews, and R. Mayeux Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease Lancet 348 1996 429 432
40. S. Waring, W. Rocca, R. Petersen, P. O'Brien, E. Tangalos, and E. Kokmen Postmenopausal estrogen replacement therapy and risk of AD: a population-based study Neurology 52 1999 965 970
41. K. Yaffe, W. Browner, J. Cauley, L. Launer, and T. Harris Association between bone mineral density and cognitive decline in older women J. Am. Geriatr. Soc. 47 1999 1176 1182
42. K. Yaffe, L. Lui, D. Grady, J. Cauley, J. Kramer, and S. Cummings Cognitive decline in women in relation to non-protein-bound oestradiol concentrations Lancet 356 2000 708 712
43. P. Zandi, M. Carlson, B. Plassman, K. Welsh-Bohmer, L. Mayer, D. Steffens, J. Breitner, and for tCCMSI Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County study JAMA 288 2002 2123 2129
44. L. Zhu, L. Fratiglioni, Z. Guo, H. Aguero-Torres, B. Winblad, and M. Viitanen Association of stroke with dementia, cognitive impairment, and functional disability in the very old: a population-based study Stroke 29 1998 2094 2099